Literature DB >> 20808343

Separating the scattering and absorption coefficients using the real and imaginary parts of the refractive index with low-coherence interferometry.

Francisco E Robles1, Adam Wax.   

Abstract

We present an analytical method that yields the real and imaginary parts of the refractive index (RI) from low-coherence interferometry measurements, leading to the separation of the scattering and absorption coefficients of turbid samples. The imaginary RI is measured using time-frequency analysis, with the real part obtained by analyzing the nonlinear phase induced by a sample. A derivation relating the real part of the RI to the nonlinear phase term of the signal is presented, along with measurements from scattering and nonscattering samples that exhibit absorption due to hemoglobin.

Entities:  

Mesh:

Year:  2010        PMID: 20808343      PMCID: PMC3306185          DOI: 10.1364/OL.35.002843

Source DB:  PubMed          Journal:  Opt Lett        ISSN: 0146-9592            Impact factor:   3.776


  10 in total

1.  Light scattering in Intralipid-10% in the wavelength range of 400-1100 nm.

Authors:  H J van Staveren; C J Moes; J van Marie; S A Prahl; M J van Gemert
Journal:  Appl Opt       Date:  1991-11-01       Impact factor: 1.980

2.  Toward assessment of blood oxygen saturation by spectroscopic optical coherence tomography.

Authors:  Dirk J Faber; Egbert G Mik; Maurice C G Aalders; Ton G van Leeuwen
Journal:  Opt Lett       Date:  2005-05-01       Impact factor: 3.776

3.  Determination of optical properties of human blood in the spectral range 250 to 1100 nm using Monte Carlo simulations with hematocrit-dependent effective scattering phase functions.

Authors:  Moritz Friebel; André Roggan; Gerhard Müller; Martina Meinke
Journal:  J Biomed Opt       Date:  2006 May-Jun       Impact factor: 3.170

4.  Are quantitative attenuation measurements of blood by optical coherence tomography feasible?

Authors:  Dirk J Faber; Ton G van Leeuwen
Journal:  Opt Lett       Date:  2009-05-01       Impact factor: 3.776

5.  Measuring morphological features using light-scattering spectroscopy and Fourier-domain low-coherence interferometry.

Authors:  Francisco E Robles; Adam Wax
Journal:  Opt Lett       Date:  2010-02-01       Impact factor: 3.776

6.  Spectroscopic phase microscopy for quantifying hemoglobin concentrations in intact red blood cells.

Authors:  YongKeun Park; Toyohiko Yamauchi; Wonshik Choi; Ramachandra Dasari; Michael S Feld
Journal:  Opt Lett       Date:  2009-12-01       Impact factor: 3.776

7.  Oxygen saturation-dependent absorption and scattering of blood.

Authors:  Dirk J Faber; Maurice C G Aalders; Egbert G Mik; Brett A Hooper; Martin J C van Gemert; Ton G van Leeuwen
Journal:  Phys Rev Lett       Date:  2004-07-08       Impact factor: 9.161

8.  Spectroscopic measurements with dispersion encoded full range frequency domain optical coherence tomography in single- and multilayered non-scattering phantoms.

Authors:  B Hermann; B Hofer; C Meier; W Drexler
Journal:  Opt Express       Date:  2009-12-21       Impact factor: 3.894

9.  Scanning fiber angle-resolved low coherence interferometry.

Authors:  Yizheng Zhu; Neil G Terry; Adam Wax
Journal:  Opt Lett       Date:  2009-10-15       Impact factor: 3.776

10.  Dual window method for processing spectroscopic optical coherence tomography signals with simultaneously high spectral and temporal resolution.

Authors:  Francisco Robles; Robert N Graf; Adam Wax
Journal:  Opt Express       Date:  2009-04-13       Impact factor: 3.894

  10 in total
  11 in total

1.  In vivo analysis of burns in a mouse model using spectroscopic optical coherence tomography.

Authors:  Jason R Maher; Volker Jaedicke; Manuel Medina; Howard Levinson; Maria Angelica Selim; William J Brown; Adam Wax
Journal:  Opt Lett       Date:  2014-10-01       Impact factor: 3.776

2.  Dispersion-based stimulated Raman scattering spectroscopy, holography, and optical coherence tomography.

Authors:  Francisco E Robles; Martin C Fischer; Warren S Warren
Journal:  Opt Express       Date:  2016-01-11       Impact factor: 3.894

3.  Structured illumination multimodal 3D-resolved quantitative phase and fluorescence sub-diffraction microscopy.

Authors:  Shwetadwip Chowdhury; Will J Eldridge; Adam Wax; Joseph A Izatt
Journal:  Biomed Opt Express       Date:  2017-04-17       Impact factor: 3.732

4.  Spatially confined quantification of bilirubin concentrations by spectroscopic visible-light optical coherence tomography.

Authors:  Colin Veenstra; Wilma Petersen; Ivo M Vellekoop; Wiendelt Steenbergen; Nienke Bosschaart
Journal:  Biomed Opt Express       Date:  2018-07-06       Impact factor: 3.732

5.  Pump-probe nonlinear phase dispersion spectroscopy.

Authors:  Francisco E Robles; Prathyush Samineni; Jesse W Wilson; Warren S Warren
Journal:  Opt Express       Date:  2013-04-22       Impact factor: 3.894

6.  Comparison of different metrics for analysis and visualization in spectroscopic optical coherence tomography.

Authors:  Volker Jaedicke; Semih Agcaer; Francisco E Robles; Marian Steinert; David Jones; Sebastian Goebel; Nils C Gerhardt; Hubert Welp; Martin R Hofmann
Journal:  Biomed Opt Express       Date:  2013-11-22       Impact factor: 3.732

7.  Nonlinear phase dispersion spectroscopy.

Authors:  Francisco E Robles; Lisa L Satterwhite; Adam Wax
Journal:  Opt Lett       Date:  2011-12-01       Impact factor: 3.776

Review 8.  Functional optical coherence tomography: principles and progress.

Authors:  Jina Kim; William Brown; Jason R Maher; Howard Levinson; Adam Wax
Journal:  Phys Med Biol       Date:  2015-05-08       Impact factor: 3.609

9.  Assessing hemoglobin concentration using spectroscopic optical coherence tomography for feasibility of tissue diagnostics.

Authors:  Francisco E Robles; Shwetadwip Chowdhury; Adam Wax
Journal:  Biomed Opt Express       Date:  2010-07-27       Impact factor: 3.732

10.  Characterizing optical properties of nano contrast agents by using cross-referencing OCT imaging.

Authors:  Jiefeng Xi; Yongping Chen; Xingde Li
Journal:  Biomed Opt Express       Date:  2013-05-09       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.